News Summary
TOBY, Inc., focused on early cancer screening, has been selected for the Mayo Clinic and Arizona State University MedTech Accelerator program. As one of ten companies chosen globally, TOBY is developing a noninvasive urine test utilizing AI and spectroscopy to detect multiple types of cancer. The program provides mentorship and resources crucial for advancing their innovative technology, which aims to fill the pressing need for accessible early cancer detection amidst rising global cancer rates.
Phoenix, AZ – TOBY, Inc., a biotechnology company dedicated to enhancing early cancer screening, has finalized its participation in the Mayo Clinic and Arizona State University Alliance for Health Care MedTech Accelerator program. This initiative, based in Phoenix, Arizona, selected TOBY as one of only ten companies from a global pool for its 2025 cohort, emphasizing the innovative potential of TOBY’s technology in the field of oncology.
TOBY Inc. is advancing a noninvasive urine spectroscopy and Artificial Intelligence (AI) platform aimed at early cancer detection. The unique urine test analyzes specific molecular signatures to facilitate early, accessible, and cost-effective cancer screening. This pioneering approach seeks to identify up to ten different types of cancer that account for over 60% of all new cancer cases worldwide.
During their time in the MedTech Accelerator, TOBY gained invaluable mentorship and strategic guidance. They also had access to crucial clinical, academic, and commercial resources that have significantly contributed to the advancement of their technology and development strategy. The Chief Executive Officer (CEO) of TOBY emphasized the program’s critical role in enhancing their developmental goals.
The urgency for better cancer screening methods has never been clearer. According to the International Agency for Research on Cancer, global cancer incidence is expected to rise significantly from 2022 to 2045. This alarming trend aligns with estimates from the National Cancer Institute, which forecasts that over 2 million people will be diagnosed with cancer in the U.S. alone by 2025. These statistics underscore the pressing need for accessible early detection options, a gap that TOBY’s innovative solution aims to fill.
TOBY’s technology leverages machine learning to detect molecular patterns associated with early-stage cancer. By employing precision spectroscopy and analyzing changes in biomarkers known as volatile organic compounds (VOCs), the urine test develops computational algorithms for effective cancer screening. The implications of having a noninvasive method for detecting various cancer types could lower the burden on patients and healthcare systems by allowing for earlier interventions, which can often lead to better outcomes.
This groundbreaking effort not only addresses critical healthcare challenges but also paves the way for advancements in cancer diagnostics, thereby offering hope for improved survival rates and quality of life for patients. TOBY’s noninvasive urine test could represent a significant leap forward in the ongoing battle against cancer, providing a solution that is both less intrusive and easier for patients to access.
As TOBY Inc. continues to innovate and progress within the MedTech realm, it remains focused on its mission to revolutionize cancer screening, making crucial diagnostics available to all those in need. More detailed information about TOBY’s initiatives and ongoing research can be found on their website.
Deeper Dive: News & Info About This Topic
HERE Resources
Phoenix Firefighters Tackle Rising Cancer Rates Amid Hazardous Exposure
Phoenix Mom Triumphs Over Stage Four Colorectal Cancer
Additional Resources
- Newswise: Lung Cancer Screening Trial
- Wikipedia: Lung Cancer
- Boston Real Estate Times: Cancer Hospital
- Google Search: Cancer Hospital Longwood Medical Area
- Stat News: Cancer Screening Disparities
- Google Scholar: Cancer Screening Disparities
- The Conversation: Breast Cancer Screenings
- Encyclopedia Britannica: Breast Cancer Screenings
- Boston Globe: Cancer Prevention Among Latinos
- Google News: Cancer Prevention Latinos
